You are here

Corporate digest

Singapore eDevelopment

CATALIST-LISTED Singapore eDevelopment (SeD) on Tuesday said its US subsidiary, Impact BioMedical, has tested two compounds that can successfully inhibit infection by the Covid-19 virus. Results from Impact BioMedical's recent molecular-docking...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes